Allogeneic Transplantation
Non-Cancerous Blood Disorder Trials
COMIRB: 21-3149
Efficacy and Safety of M281 in Adults with Warm Autoimmune Hemolytic Anemia: A Multicenter, Randomized, Double-blind, Placebo-controlled Study with a Long-term Open-label Extension
Principal Investigator: Ara Metjian
Eligibility: Ages ≥ 18; Diagnosed with warm autoimmune hemolytic anemia (wAIHA) for at least 3 months; must be able to understand and voluntarily provide written informed consent
Request an Appointment
If you would like to schedule an appointment, please give us a call.
Our intake coordinator will help you navigate the process of becoming a new patient including helping you obtain the necessary referrals, get the necessary medical records transferred, and coordinate care with your existing physicians. We are available to answer your questions about our clinic, your treatment, and participation in ongoing clinical trials.